Cytokine secretion and NK cell activity in human ADAM17 deficiency (Q38810631)

6 September 2017

Cytokine secretion and NK cell activity in human ADAM17 deficiency (English)

1 reference

6 September 2017

5

Eitan Wong

1 reference

6 September 2017

Pinchas Tsukerman

1

1 reference

6 September 2017

Eli M Eisenstein

2

1 reference

6 September 2017

Maor Chavkin

3

1 reference

6 September 2017

Dominik Schmiedel

4

1 reference

6 September 2017

Marion Werner

6

1 reference

6 September 2017

Barak Yaacov

7

1 reference

6 September 2017

Diana Averbuch

8

1 reference

6 September 2017

Vered Molho-Pessach

9

1 reference

6 September 2017

Polina Stepensky

10

1 reference

6 September 2017

Noa Kaynan

11

1 reference

6 September 2017

Yotam Bar-On

12

1 reference

6 September 2017

Einat Seidel

13

1 reference

6 September 2017

Rachel Yamin

14

1 reference

6 September 2017

Irit Sagi

15

1 reference

6 September 2017

Orly Elpeleg

16

1 reference

6 September 2017

Ofer Mandelboim

17

1 reference

6 September 2017

language of work or name

English

0 references

publication date

16 December 2015

1 reference

6 September 2017

1 reference

6 September 2017

6

1 reference

6 September 2017

42

1 reference

6 September 2017

44151-44160

1 reference

A human laterality disorder associated with a homozygous WDR16 deletion

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

Human NK cells: from surface receptors to the therapy of leukemias and solid tumors

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

Expansion of CD16 positive and negative human NK cells in response to tumor stimulation

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

Metalloproteinases and their natural inhibitors in inflammation and immunity.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

Controlling natural killer cell responses: integration of signals for activation and inhibition

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17).

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

Activating natural cytotoxicity receptors of natural killer cells in cancer and infection

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

Virus-mediated inhibition of natural cytotoxicity receptor recognition

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

Antibody therapy of cancer

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

ADAM17: a molecular switch to control inflammation and tissue regeneration

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

Oncogenic stress sensed by the immune system: role of natural killer cell receptors

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

Structural and Inhibition Analysis Reveals the Mechanism of Selectivity of a Series of Aggrecanase Inhibitors

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

Human natural killer cells

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

Signal transduction by Fc gamma RIII (CD16) is mediated through the gamma chain

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

A transforming Src mutant increases the bioavailability of EGFR ligands via stimulation of the cell-surface metalloproteinase ADAM17.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

ADAM17-mediated shedding of FcγRIIIA on human NK cells: identification of the cleavage site and relationship with activation

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

Inflammatory skin and bowel disease linked to ADAM17 deletion

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4792548

Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes

31 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26683521

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.18632/ONCOTARGET.6629

1 reference

6 September 2017

1 reference

6 September 2017

1 reference